Testing effectiveness (Phase 2)Ended earlyNCT01942993What this trial is testingThe Effects of Treatment With Vemurafenib on the Immune System in Advanced MelanomaWho this might be right forMelanoma Philip Friedlander 3
Not applicableActive Not RecruitingNCT07428252What this trial is testingGastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant MelanomaWho this might be right forMetastatic Malignant Melanoma Institute of Oncology Ljubljana 150
Not applicableStudy completedNCT07256184What this trial is testingPrognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center AnalysisWho this might be right forMetastatic Malignant Melanoma Ankara Etlik City Hospital 232
Early research (Phase 1)Temporarily pausedNCT05967533What this trial is testingThe Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint InhibitorsWho this might be right forAdvanced Colorectal CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+13 more University of California, Davis 100
Testing effectiveness (Phase 2)Looking for participantsNCT04331093What this trial is testingNeoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral MelanomaWho this might be right forAcral Melanoma Di Wu 40
Testing effectiveness (Phase 2)Ended earlyNCT02796352What this trial is testingA Phase II Study of High Dose Bolus IL2 in Patients With Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy: Efficacy and Biomarker StudyWho this might be right forMelanoma Ahmad Tarhini 1
Early research (Phase 1)Study completedNCT02716948What this trial is testingSRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or SpineWho this might be right forMetastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the SpineStage IV Skin Melanoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Testing effectiveness (Phase 2)Study completedNCT00003308What this trial is testingRadiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or SarcomaWho this might be right forKidney CancerMelanoma (Skin)Metastatic Cancer+2 more Eastern Cooperative Oncology Group
Not applicableStudy completedNCT03112668What this trial is testingAcceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersWho this might be right forMalignant Female Reproductive System NeoplasmMalignant Hepatobiliary NeoplasmPartner+36 more Rutgers, The State University of New Jersey 14
Very early researchLooking for participantsNCT04741997What this trial is testingAdjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in MelanomaWho this might be right forMelanoma Stage IIIMelanoma Stage IVBRAF V600 Mutation H. Lee Moffitt Cancer Center and Research Institute 50
Large-scale testing (Phase 3)Study completedNCT00003027What this trial is testingCombination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) Eastern Cooperative Oncology Group 482
Testing effectiveness (Phase 2)Study completedNCT05304546What this trial is testingOvercoming Primary Resistance to Immunotherapy in Metastatic MelanomaWho this might be right forMalignant MelanomaMetastatic MelanomaImmunotherapy+2 more Dr. Ronnie Shapira 1
Testing effectiveness (Phase 2)Ended earlyNCT04455503What this trial is testingStudy of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1Who this might be right forMelanoma Stage IVMelanoma Stage III Evaxion Biotech A/S 15
Early research (Phase 1)Study completedNCT01910181What this trial is testingVemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic MelanomaWho this might be right forMalignant Melanoma Hoffmann-La Roche 46
Testing effectiveness (Phase 2)UnknownNCT02990416What this trial is testingA-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV MelanomaWho this might be right forStage IV Melanoma Virogen Biotechnology Inc. 63
Testing effectiveness (Phase 2)WithdrawnNCT02535078What this trial is testingPhase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous MelanomaWho this might be right forMalignant Melanoma Immunocore Ltd
Testing effectiveness (Phase 2)Ended earlyNCT00704938What this trial is testingGene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic CancerWho this might be right forKidney CancerMelanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific National Institutes of Health Clinical Center (CC) 3
Testing effectiveness (Phase 2)Ended earlyNCT01696045What this trial is testingPhase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant MelanomaWho this might be right forMalignant Melanoma Bristol-Myers Squibb 14
Testing effectiveness (Phase 2)Study completedNCT00471887What this trial is testingTicilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV MelanomaWho this might be right forMelanoma (Skin) Jonsson Comprehensive Cancer Center 32
Early research (Phase 1)Ended earlyNCT00492440What this trial is testingInterleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Cytheris SA 9